Characteristics of the study population
Out of the total cohort, 195 patients were incorporated into the study.
This comprised 32 cases (those experiencing significant clinical adverse
events) and 163 controls (those without any adverse events).Table 1 delineates the baseline characteristics of these
patients. Out of the 32 adverse events documented, 11 were strokes
(34.3%), 3 were angina episodes (9.4%), 4 were myocardial infarctions
(12.5%), and 14 were TIAs (43.8%). Notably, the foundational
characteristics of the case group mirrored those of the control group.